Republic Services Inc. Common Stock vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Republic Services Inc. Common Stock trades at $226.9 (market cap $68.73B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $19.5 (market cap $59.39B). The key difference: Republic Services Inc. Common Stock is the larger of the two by market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays the higher dividend (3.24%). Which is the better fit depends on your goals.
| RSG | TAK | |
|---|---|---|
Market Cap | $68.73B | $59.39B |
Volume | 1,226,777 | 4,676,421 |
Sector | Industrials | Health |
52-Week High | $232.27 | $19.05 |
52-Week Low | $197.73 | $13.23 |
Enterprise Value | $82.91B | $87.25B |
Dividend Yield | 1.19% | 3.24% |
Typical Hold Time | — | 6 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TAK trades at $18.52, down 0.86% on the day. The stock shows mixed signals with a bullish technical outlook from moving averages but neutral oscillators. Recent financials reveal a net income margin of -3.54% for 2026, though revenue remains stable near $4.6 trillion. Positive developments include the launch of ORZEYFUL for narcolepsy and FDA priority review for zasocitinib, highlighting a robust pipeline. Cash flow improved to $209.8 billion in 2026 from a negative position in 2025.
Outlook: TAK's strong analyst support (83% buy ratings) and promising drug pipeline offer growth potential, but profitability concerns and high P/E of 51.56 pose risks. Investors should weigh pipeline successes against current negative margins and elevated valuation.
Trailing returns across standard periods
Latest headlines on both assets
Republic Services Inc. is a waste management company that provides non-hazardous solid waste collection, transfer, disposal, and recycling services across North America.
Read more on RSG →Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →